{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T14:40:35Z","timestamp":1784299235365,"version":"3.55.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>There is growing evidence that severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) or COVID-19 infection is associated with the development of immune mediated neuropathies like chronic inflammatory demyelinating polyneuropathy (CIDP), but the impact of SARS-CoV-2 vaccination and COVID-19 infection on genetic disorders such as Charcot\u2013MarieTooth (CMT) remains unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>A 42-year-old male with occulted CMT neuropathy type lA (CMT1A) who developed limb numbness and weakness after the second SARS-CoV-2-vaccination was confirmed by identifying characteristic repeats in the p11.2 region of chromosome 17. Due to the progressive deterioration of muscle strength over 8\u2009weeks, limb atrophy, moderately elevated protein counts in the cerebrospinal fluid, and significant improvement with intravenous human immunoglobulin, which were characteristic of acquired inflammatory neuropathies, he was eventually diagnosed with CIDP superimposed on CMT1A. However, after a three-month plateau, the patient contracted COVID-19, which led to repeated and worsening symptoms of limb weakness and atrophy, thus was diagnosed with a recurrence of CIDP and treated with Intravenous immunoglobulin and methylprednisolone 500\u2009mg\/d for 5 consecutive days, followed by oral prednisone and mycophenolate mofetil tablets. On 2\u2009month follow-up, he exhibited remarkable clinical improvement and could walk independently with rocking gait. After 1\u2009year of follow-up, the patient\u2019s condition was stable without further change.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our case indicates that CMT1A can deteriorate after SARS-CoV-2 vaccination. Thus, SARS-CoV-2 vaccination should be considered a potential predisposing factor for CMT1A worsening. The possible superposition of CMTIA and CIDP in the context of SARS-CoV-2 infection or immunity suggests that any clinical exacerbation in patients with CMT1A should be carefully evaluated to rule out treatable superposition inflammation. In addition, electrophysiological and imaging examination of the proximal nerves, such as the axillary nerve, is helpful for the diagnosis of CIDP.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2024.1358881","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T04:53:15Z","timestamp":1712551995000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Case report: Chronic inflammatory demyelinating polyneuropathy superimposed on Charcot\u2013Marie-tooth type 1A disease after SARS-CoV-2 vaccination and COVID-19 infection"],"prefix":"10.3389","volume":"15","author":[{"given":"Da","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weinv","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongfeng","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1186\/s12883-022-02929-2","article-title":"Hypoglossal nerve palsy after SARS-CoV-2 vaccination - report of two cases","volume":"22","author":"Panholzer","year":"2022","journal-title":"BMC Neurol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1038\/s41591-021-01556-7","article-title":"Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection","volume":"27","author":"Patone","year":"2021","journal-title":"Nat Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci12101396","article-title":"Adherence and Reactogenicity to vaccines against SARS-COV-2 in 285 patients with neuropathy: a multicentric study","volume":"12","author":"Iacono","year":"2022","journal-title":"Brain Sci"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s12026-023-09406-z","article-title":"Chronic inflammatory demyelinating polyneuropathy after SARS-CoV2 vaccination: update of the literature and patient characterization","volume":"71","author":"Ginanneschi","year":"2023","journal-title":"Immunol Res"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1136\/practneurol-2015-001095","article-title":"A practical approach to the genetic neuropathies","volume":"15","author":"Rossor","year":"2015","journal-title":"Pract Neurol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.nmd.2013.01.010","article-title":"Rapidly progressive asymmetrical weakness in Charcot-Marie-tooth disease type 4J resembles chronic inflammatory demyelinating polyneuropathy","volume":"23","author":"Cottenie","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/brain\/awh017","article-title":"Coexistent hereditary and inflammatory neuropathy","volume":"127","author":"Ginsberg","year":"2004","journal-title":"Brain"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/jns.12362","article-title":"Sporadic hereditary neuropathies misdiagnosed as chronic inflammatory demyelinating polyradiculoneuropathy: pitfalls and red flags","volume":"25","author":"Campagnolo","year":"2020","journal-title":"J Peripher Nerv Syst"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1046\/j.1529-8027.2000.00014.x","article-title":"Chronic inflammatory demyelinating polyneuropathy caused by HIV infection in a patient with asymptomatic CMT 1A","volume":"5","author":"Rajabally","year":"2000","journal-title":"J Peripher Nerv Syst"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/mus.24207","article-title":"INCAT disability score: a critical analysis of its measurement properties","volume":"50","author":"Breiner","year":"2014","journal-title":"Muscle Nerve"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1212\/wnl.41.3.437","article-title":"Corticosteroid-responsive dominantly inherited neuropathy in childhood","volume":"41","author":"Bird","year":"1991","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1212\/wnl.52.4.859","article-title":"Acute inflammatory neuropathy in Charcot-Marie-tooth disease","volume":"52","author":"Malandrini","year":"1999","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s10072-017-3195-z","article-title":"Reversible inflammatory neuropathy superimposed on Charcot-Marie-tooth type 1A disease","volume":"39","author":"Gazulla","year":"2018","journal-title":"Neurol Sci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1136\/jnnp-2015-310835","article-title":"Hereditary and inflammatory neuropathies: a review of reported associations, mimics and misdiagnoses","volume":"87","author":"Rajabally","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1111\/ene.14959","article-title":"European academy of neurology\/peripheral nerve society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force-second revision","volume":"28","author":"Van den Bergh","year":"2021","journal-title":"Eur J Neurol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3760\/cma.j.cn113694-20220627-00507","article-title":"The guideline of diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy","volume":"56","year":"2023","journal-title":"Chin J Neurol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","article-title":"European Federation of Neurological Societies\/peripheral nerve society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the peripheral nerve society - first revision","volume":"17","author":"van den Bergh","year":"2010","journal-title":"Eur J Neurol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1136\/jnnp.69.6.799","article-title":"Steroid responsive polyneuropathy in a family with a novel myelin protein zero mutation","volume":"69","author":"Donaghy","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1212\/wnl.59.5.767","article-title":"Corticosteroid-responsive asymmetric neuropathy with a myelin protein zero gen mutation","volume":"59","author":"Watanabe","year":"2002","journal-title":"Neurology"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/0896-6273(90)90057-m","article-title":"Protein zero of peripheral nerve myelin: biosynthesis, membrane insertion, and evidence for homotypic interaction","volume":"4","author":"D'Urso","year":"1990","journal-title":"Neuron"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/344871a0","article-title":"Role of myelin P0 protein as a homophilic adhesion molecule","volume":"344","author":"Filbin","year":"1990","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/0896-6273(88)90103-1","article-title":"Unwrapping the genes of myelin","volume":"1","author":"Lemke","year":"1988","journal-title":"Neuron"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1136\/jnnp.72.2.230","article-title":"Immunological study of hereditary motor and sensory neuropathy type 1a (HMSN1a)","volume":"72","author":"Gabriel","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s10072-020-04789-5","article-title":"CIDP, CMT1B, or CMT1B plus CIDP?","volume":"42","author":"Cardellini","year":"2021","journal-title":"Neurol Sci"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2174\/1389202919666180330153316","article-title":"A review of copy number variants in inherited neuropathies","volume":"19","author":"Salpietro","year":"2018","journal-title":"Curr Genomics"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/mgg3.390","article-title":"Structural variations causing inherited peripheral neuropathies: a paradigm for understanding genomic organization, chromatin interactions, and gene dysregulation","volume":"6","author":"Cutrupi","year":"2018","journal-title":"Mol Genet Genomic Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1212\/01.wnl.0000059262.34846.8a","article-title":"Does CMT1A homozygosity cause more severe disease with root hypertrophy and higher CSF proteins?","volume":"60","author":"Pareyson","year":"2003","journal-title":"Neurology"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1212\/wnl.49.6.1635","article-title":"Gene dosage effects in hereditary peripheral neuropathy. Expression of peripheral myelin protein 22 in Charcot-Marie-tooth disease type 1A and hereditary neuropathy with liability to pressure palsies nerve biopsies","volume":"49","author":"Gabriel","year":"1997","journal-title":"Neurology"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1212\/wnl.48.2.445","article-title":"Underexpression of messenger RNA for peripheral myelin protein 22 in hereditary neuropathy with liability to pressure palsies","volume":"48","author":"Schenone","year":"1997","journal-title":"Neurology"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1385\/nmm:8:1-2:175","article-title":"Role of immune cells in animal models for inherited peripheral neuropathies","volume":"8","author":"Wang","year":"2006","journal-title":"NeuroMolecular Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/ene.14044","article-title":"Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP database","volume":"27","author":"Doneddu","year":"2020","journal-title":"Eur J Neurol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/ana.26144","article-title":"Guillain-Barre syndrome variant occurring after SARS-CoV-2 vaccination","volume":"90","author":"Allen","year":"2021","journal-title":"Ann Neurol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"105960","DOI":"10.1016\/j.ijantimicag.2020.105960","article-title":"Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection","volume":"55","author":"Fantini","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/mus.26029","article-title":"Nerve ultrasound in polyneuropathies","volume":"57","author":"Telleman","year":"2018","journal-title":"Muscle Nerve"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barre syndrome in ten steps","volume":"15","author":"Leonhard","year":"2019","journal-title":"Nat Rev Neurol"}],"updated-by":[{"DOI":"10.3389\/fneur.2024.1465995","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000}}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1358881\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T11:48:48Z","timestamp":1722944928000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1358881\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,8]]},"references-count":35,"alternative-id":["10.3389\/fneur.2024.1358881"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1358881","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fneur.2024.1465995","asserted-by":"object"}]},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,8]]},"article-number":"1358881"}}